This article explores whether operations for carotid artery diseases reduce the risk of dementia.
Cross-sectional and longitudinal soluble TREM2 levels in CSF according to estimated years to symptom onset (EYO) in carriers and non-carriers of pathogenic variants.
An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.
An article on dementia risk, in the context of SDGs 3 and 10, focusing specifically on the association between ethnicity, socioeconomic deprivation, and dementia risk.
In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.
Elsevier,

Kanski's Synopsis of Clinical Ophthalmology (Fourth edition)
2023, Pages 289-303

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insight on a group of inherited disorders that have an effect on the RPE-photoreceptor complex and choriocapillaris, causing a range of symptoms and in many cases gradual visual loss.
This chapter briefly reviews the history of ketamine, explores proposed mechanisms of action, outlines data pertaining to efficacy and safety, and considers “real-world” usage and the challenges to implementation.
This chapter clearly defines “treatment-resistant depression (TRD)” and “difficult-to-treat depression (DTD)" to help clinicians to understand how to treat patients with depression.
Elsevier,

Healthcare Strategies and Planning for Social Inclusion and Development, Volume 2: Social, Economic, and Health Disparities of Rural Women, 2022, Pages 115-158

This chapter focuses on how good quality foods prevent malnutrition in all its forms.
Ukrainian Refugees' experience at Cancer Centers in Poland and Italy.
A Viewpoint article on the unfolding health and humanitarian crisis due to the conflict in Ukraine, in the context of SDGs 3 and 16, focusing specifically on the impact on people with HIV and opioid use disorder.

Pages